Enteric Glial Cells in Parkinson Disease

Enteric Glial Cells in Parkinson Disease

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Enteric Glial Cells in Parkinson Disease</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Enteric Nervous System</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Gastrointestinal tract</td>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>Enteric glial cells (EGCs)</td>
</tr>
<tr>
<td class="label">Markers</td>
<td>GFAP, S100B, Sox10</td>
</tr>
<tr>
<td class="label">Lineage</td>
<td>Neural crest-derived</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0007011](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0007011)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0007011](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0007011)</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:4040002](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4040002)</td>
</tr>
<tr>
<td class="label">Symptom</td>
<td>Prevalence</td>
</tr>
<tr>
<td class="label">Constipation</td>
<td>60-80%</td>
</tr>
<tr>
<td class="label">Gastroparesis</td>
<td>30-50%</td>
</tr>

Enteric Glial Cells in Parkinson Disease

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Enteric Glial Cells in Parkinson Disease</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Enteric Nervous System</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Gastrointestinal tract</td>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>Enteric glial cells (EGCs)</td>
</tr>
<tr>
<td class="label">Markers</td>
<td>GFAP, S100B, Sox10</td>
</tr>
<tr>
<td class="label">Lineage</td>
<td>Neural crest-derived</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0007011](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0007011)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0007011](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0007011)</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:4040002](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4040002)</td>
</tr>
<tr>
<td class="label">Symptom</td>
<td>Prevalence</td>
</tr>
<tr>
<td class="label">Constipation</td>
<td>60-80%</td>
</tr>
<tr>
<td class="label">Gastroparesis</td>
<td>30-50%</td>
</tr>
<tr>
<td class="label">Small intestinal bacterial overgrowth</td>
<td>25-30%</td>
</tr>
<tr>
<td class="label">Dysphagia</td>
<td>20-40%</td>
</tr>
</table>

Enteric Glial Cells In Parkinson Disease is a cell type relevant to neurodegenerative disease research. This page covers its role in brain function, involvement in disease processes, and significance for therapeutic strategies.

Overview

Multi-Taxonomy Classification

Taxonomy Database Cross-References

Morphology & Electrophysiology

• Morphology: enteric neuron (source: Cell Ontology)
• Morphology can be inferred from Cell Ontology classification

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:0007011)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0007011)
• [OBO Foundry (CL:0007011)](http://purl.obolibrary.org/obo/CL_0007011)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)
• [PanglaoDB](https://panglaodb.se/)

Taxonomy & Classification

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:0007011)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0007011)
• [OBO Foundry (CL:0007011)](http://purl.obolibrary.org/obo/CL_0007011)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [PanglaoDB](https://panglaodb.se/)

Enteric Glial Cell Biology

Types of Enteric Glia

The ENS contains two main glial cell populations:

• Enteric neural crest-derived glia (ENCG): Myelinating-like glia
• Enteric mesenchymal glia (EMG): Non-myelinating, supportive

Functions in Healthy Gut

• Neuronal support: Metabolic and trophic support
• Barrier maintenance: Tight junction regulation
• Immune modulation: Cytokine signaling
• Neurotransmitter regulation: GABA, 5-HT modulation
• Mucus production: Mucin secretion coordination

Enteric Glia-Neuron Interactions

EGCs communicate with enteric neurons through:

• Glial-neuronal signaling: ATP and glutamate release
• Calcium waves: Propagation via gap junctions
• Neurotrophic factors: GDNF family support

Role in Parkinson Disease

Alpha-Synuclein Pathology

The Enteric Nervous System as Initiation Site:

• Early alpha-syn deposition: Found in 50-75% of PD patients
• Vagal nerve pathway: Retrograde transport to dorsal motor nucleus
• Braak staging: Stages 1-2 involve enteric nervous system
• Lewy bodies: Alpha-syn+ inclusions in EGCs

Mechanisms of Pathology Spread

Enteric glial alpha-syn → Vagal nerve uptake → Dorsal motor nucleus →
Nigral dopaminergic neurons → Lewy body formation

GI Dysfunction in PD

Gut-Brain Axis in PD

Microbiome Interactions:

• Altered microbiome in PD patients
• Bacterial metabolites cross-talk with EGCs
• Inflammation triggers alpha-syn misfolding

• EGCs express pattern recognition receptors
• Cytokine release in response to pathogens
• Chronic inflammation promotes neurodegeneration

Research Findings

Histopathological Studies

• EGC alpha-syn: Positive in 70% of PD patients
• Glial changes: Reactive gliosis in PD intestine
• Neuronal loss: Myenteric plexus degeneration

Animal Models

• α-syn transgenic mice: Enteric glia show dysfunction
• MPTP model: GI complications reproduced
• α-syn preformed fibrils: Bidirectional gut-brain spread

Clinical Correlations

• Prodromal markers: Constipation predates motor symptoms by years
• Treatment response: GI symptoms correlate with levodopa efficacy
• Disease progression: Enteric pathology predicts cognitive decline

Therapeutic Implications

Current Approaches

• Probiotic interventions: Restore microbiome balance
• Anti-inflammatory agents: Reduce EGC activation
• Antioxidants: Protect enteric neurons

Emerging Therapies

• GDNF delivery: Support enteric neuron survival
• Alpha-syn aggregation inhibitors: Prevent spread
• Vagal nerve modulation: Interrupt pathology propagation

See Also

• [Enteric Nervous System](/mechanisms/enteric-nervous-system)
• [Parkinson Disease](/diseases/parkinsons-disease)
• [Gut-Brain Axis](/entities/gut-brain-axis)
• [Alpha-Synuclein Pathology](/proteins/alpha-synuclein)